Weight Managemet Raw Survodutide Reta Tirzepatide Peptide Fast delivery
6 Inquiries
2805997-46-8
Pharmaceutical Grade
99%
shanghai
HB
5mg 10mg / vial ,10vials/box
2026-10-13
GLP-1,Retatrutide,Selank,Tirzepatide
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Survodutide
Other Name:Survodutide;BI 456906;Survodutide Peptide;Survodutide(BI 456906) 10MG;Survodutide acetate;Suvorouti;Swertide peptide;Suvodutide
CAS No.:2805997-46-8
Molecular Weight:0
EC Number:997-146-8
Color/Form:White to off-white
Categories:
Research-
Class:
Dual agonist — GIPR, GLP-1R
Status:FDA-approved (Mounjaro / Zepbound)
Mechanism:Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.
EC50 (Human GLP1R):0.934 nM
EC50 (Human GIPR):0.0224 nM
Source:Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI
Clinical Development:NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503
FDA:Mounjaro, Zepbound (approved 2022-05-13)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
GLP-1,Retatrutide,Selank,Tirzepatide
-
Location:
Room 2012, No. 6-143, Section 2, Shanghai Road, Guta District, Jinzhou City, Liaoning Province
-
Payment Terms:
TT against copy of documents,L/C,TT against B/L draft before shipment
-
Average lead Time:
1
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
5-10
-
Year of Establishment:
2024
-
-
Inquiry History6 Inquiries
Country Product Purchase Quantity Date Posted
United States
Survodutide cas 2805997-46-8
2 MT Nov 14, 2025
United States
Survodutide
10 MG Oct 7, 2024
United States
Survodutide 10MG
10 MG Nov 17, 2025
Ecuador
Survodutide
10 MG Jun 17, 2026
United States
urvodutide
10 G Aug 10, 2025
Bangladesh
Survodutide
1 KG Jul 3, 2024 Post an enquiry for this product
Cool and Dry Place